Chapter 1. Enzyme immunoassays (EIA)-based devices market- Scope & Methodology
1.1    Market Segmentation
1.2    Assumptions
1.3    Research Methodology
1.4    Primary Sources
1.5    Secondary Sources
Chapter 2. Enzyme immunoassays (EIA)-based devices market- Executive Summary
2.1    Market Size & Forecast – (2023 – 2030) ($M/$Bn)
2.2    Key Trends & Insights
2.3    COVID-19 Impact Analysis
          2.3.1    Impact during 2023 – 2030
          2.3.2    Impact on Supply – Demand
Chapter 3. Enzyme immunoassays (EIA)-based devices market- Competition Scenario
3.1    Market Share Analysis
3.2    Product Benchmarking
3.3    Competitive Strategy & Development Scenario
3.4    Competitive Pricing Analysis
3.5    Supplier - Distributor Analysis
Chapter 4. Enzyme immunoassays (EIA)-based devices market- Entry Scenario
4.1     Case Studies – Start-up/Thriving Companies
4.2     Regulatory Scenario - By Region
4.3    Customer Analysis
4.4     Porter's Five Force Model
          4.4.1     Bargaining Power of Suppliers
          4.4.2     Bargaining Powers of Customers
          4.4.3    Threat of New Entrants
          4.4.4    .Rivalry among Existing Players
          4.4.5    Threat of Substitutes
Chapter 5. Enzyme immunoassays (EIA)-based devices market- Landscape
5.1     Value Chain Analysis – Key Stakeholders Impact Analysis
5.2    Market Drivers
5.3    Market Restraints/Challenges
5.4    Market Opportunities 
Chapter 6. Enzyme immunoassays (EIA)-based devices market- By Product 
6.1    Reagents & Kits
6.2    ELISA Reagents & Kits    
6.3    Rapid Test Reagents & Kits          
6.4    ELISPOT Reagents & Kits              
6.5    Western Blot Reagents & Kits    
6.6    Other Reagents & Kits  
6.7    Analyzers/Instruments
6.8    Open Ended Systems
6.9    Closed Ended Systems
6.10    Software & Services
Chapter 7. Enzyme immunoassays (EIA)-based devices market- By Specimen 
7.1    Blood  
7.2    Saliva    
7.3    Urine    
7.4    Other Specimens      
Chapter 8. Enzyme immunoassays (EIA)-based devices market- By Technology 
8.1    Radioimmunoassay (RIA)
8.2    Enzyme Immunoassays (EIA)Rapid Test
8.3    Chemiluminescence Immunoassays (CLIA)
8.4    Fluorescence Immunoassays (FIA)
8.5    Others
Chapter 9. Enzyme immunoassays (EIA)-based devices market- By Application
9.1    Therapeutic Drug Monitoring
9.2    Oncology
9.3    Cardiology
9.4    Endocrinology
9.5    Infectious Disease Testing
9.6    Autoimmune Diseases
9.7    Others
Chapter 10. Enzyme immunoassays (EIA)-based devices market- By End-use 
10.1    Hospitals
10.2    Blood Banks
10.3    Clinical Laboratories
10.4    Pharmaceutical and Biotech Companies
10.5    Academic Research Centers
10.6    Others
Chapter 11. Enzyme immunoassays (EIA)-based devices market- By Region
11.1    North America
11.2    Europe
11.3    Asia-Pacific
11.4    Latin America
11.5    The Middle East
11.6    Africa
Chapter 12. Enzyme immunoassays (EIA)-based devices market- Company Profiles – (Overview, Product Portfolio, Financials, Developments)
12.1    Company 1
12.2    Company 2
12.3    Company 3
12.4    Company 4
12.5    Company 5
12.6    Company 6
12.7    Company 7
12.8    Company 8
12.9    Company 9
12.10    Company 10

Download Sample